Serving To Educate Primary Care Clinicians On Metabolic Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Prescriber's Letter February 2016
  • What are the new warnings about the SGLT2 inhibitors?
  • Do the SGLT2 inhibitors cause bone fractures, genital yeast infections, urinary tract infections, acute renal failure, or ketoacidosis?
  • What is the incidence of bone fractures, genital yeast infections, UTIs and ketoacidosis with the flozins?
  • How should you monitor patients on SGLT2 inhibitors?
For answers see our article: More warnings for the SGLT2 inhibitors (Invokana, etc) will increase concerns about their safety

If you would like to access this month's full free article on Antithrombotics from Prescriber's letter, please click here

Prescriber's Letter offers PCMG Members a 10% discount at two subscription levels:

The Gold Subscription is $129  and includes CME

The Platinum Subscription is $189 and provides enhanced CME and Live Webinar access 

Enter Discount Code PCMG15 when ordering either subscription HERE